RECALL RECORD — CLASS IRecall closedF-2223-2014/FDA enforcement

Pran Spice Powder Turmeric, 14.10 OZ

What you need to know

Class I
  • What happened

    Elevated levels of lead.

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. Lead is a toxic heavy metal with no safe blood lead level in children.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall closed · classified by the FDADistribution not listedMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameFahman Enterprises, INC
Recalling firmFahman Enterprises, INCDallas, TX, United States
UPC / barcodes
8 31730 00502 3
Lot / date codes
  • Best Before 25 JAN 15
Distribution area

Dallas, Texas area

United States

Quantity affected4 cases
Recall initiationFDA report date: July 30, 2014
FDA recall numberF-2223-2014

Beyond the headline

The recall, in context

Fahman Enterprises, INC initiated this food recall on October 17, 2013. The FDA enforcement report states: Elevated levels of lead. The FDA report lists distribution as: Dallas, Texas area.

The FDA enforcement report describes the reason as: Elevated levels of lead.

Pran Spice Powder Turmeric, 14.10 OZ was made or distributed by Fahman Enterprises, INC in Dallas, TX, United States. This page reflects FDA report F-2223-2014, dated July 30, 2014.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, lead is a toxic heavy metal with no safe blood lead level in children.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Lead contamination

Possible health effects

Lead can affect the nervous system and is especially harmful to children and pregnant people. Symptoms may include abdominal pain, constipation, fatigue or headaches, but some exposed people have no obvious symptoms.

When symptoms may appear

Health effects depend on the amount and duration of exposure; there is no safe blood lead level in children.

Higher-risk groups

Infants, young children, pregnant people and anyone with repeated exposure are at greatest risk.

What to do now

  1. 1Stop using or eating the affected product and prevent children from handling it.
  2. 2Keep the packaging and ask the retailer or manufacturer about a refund; follow local guidance for safe disposal.
  3. 3If a child or pregnant person may have been exposed, contact a healthcare professional about blood lead testing.

Do not use home remedies or ignore possible exposure; clinical testing is the appropriate next step.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Pran Spice Powder Turmeric, 14.10 OZ recall?

Fahman Enterprises, INC recalled Pran Spice Powder Turmeric, 14.10 OZ in an FDA Class I enforcement action reported as F-2223-2014. Elevated levels of lead.

What injuries or health effects are linked to lead contamination?

Lead can affect the nervous system and is especially harmful to children and pregnant people. Symptoms may include abdominal pain, constipation, fatigue or headaches, but some exposed people have no obvious symptoms.

How quickly can Lead contamination symptoms appear?

Health effects depend on the amount and duration of exposure; there is no safe blood lead level in children.

Who is most at risk from Lead contamination?

Infants, young children, pregnant people and anyone with repeated exposure are at greatest risk.

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Stop using or eating the affected product and prevent children from handling it. Keep the packaging and ask the retailer or manufacturer about a refund; follow local guidance for safe disposal. If a child or pregnant person may have been exposed, contact a healthcare professional about blood lead testing.

How do I get a refund from Fahman Enterprises, INC?

Contact the recalling company or the retailer where you purchased the product, quote the FDA recall number and ask about a refund or replacement. Keep the packaging, lot code and proof of purchase where possible. The FDA does not issue consumer refunds. Reference FDA recall F-2223-2014 and keep the packaging, lot code and proof of purchase if you have them.

Is the Fahman Enterprises, INC recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-2223-2014. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Fahman Enterprises, INC

View brand

Related alerts

Recent Lead recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.